Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries

INTRODUCTION: Various treatment options are available for metastatic hormone-sensitive prostate cancer. This study aimed to quantify how men with prostate cancer in the United Kingdom (UK), Germany, and Spain perceive the risks and benefits of hypothetical abiraterone acetate plus prednisone treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: de Freitas, Hayley M., Ito, Tetsuro, Hadi, Monica, Al-Jassar, Gemma, Henry-Szatkowski, Mickaël, Nafees, Beenish, Lloyd, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824341/
https://www.ncbi.nlm.nih.gov/pubmed/30617763
http://dx.doi.org/10.1007/s12325-018-0861-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824341/
https://www.ncbi.nlm.nih.gov/pubmed/30617763
http://dx.doi.org/10.1007/s12325-018-0861-3

Ejemplares similares